Trials / Terminated
TerminatedNCT02530307
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Dart NeuroScience, LLC · Industry
- Sex
- All
- Age
- 21 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, placebo-controlled parallel group outpatient study that will utilize standard stroke rehabilitation outcome measures, as well as fMRI techniques in a subset of subjects, to evaluate the effect of HT-3951 on motor recovery and behavior in medically stable subjects following ischemic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HT-3951 | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
- First posted
- 2015-08-21
- Last updated
- 2018-02-01
Locations
18 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02530307. Inclusion in this directory is not an endorsement.